Revolution Medicines (RVMD) Treasury Shares (2018 - 2026)

Revolution Medicines' Treasury Shares history runs 9 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 33.82% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $5.1 million (up 33.82% YoY), while the FY2025 annual figure was $3.9 million, up 36.56% from the prior year.
• Treasury Shares was $5.1 million for Q1 2026 at Revolution Medicines, up from $3.9 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.1 million in Q1 2026 to a low of $272.0 in Q4 2022.
• Historically, Treasury Shares has averaged $2.4 million across 5 years, with a median of $2.9 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares plunged 99.97% in 2023, then surged 1102504.81% in 2024.
• A 5-year view of Treasury Shares shows it stood at $272.0 in 2022, then gained by 6.99% to $291.0 in 2023, then jumped by 979319.93% to $2.9 million in 2024, then surged by 36.56% to $3.9 million in 2025, then jumped by 32.12% to $5.1 million in 2026.
• The last three Treasury Shares figures came in at $5.1 million (Q1 2026), $3.9 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.